Ginkgo Bioworks Holdings, Inc. (DNA)
$7.03-$0.30 (-4.13%) Today
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 1,082 | $8K |
| Grant or award | 14 | 1,122,389 | |
| Option exercise | 8 | 4,458 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Steven P. Coen - Officer | Option exercise | Class A Common Stock | 587 | - | - | |
| Steven P. Coen - Officer | Option exercise | Class A Common Stock | 156 | - | - | |
| Steven P. Coen - Officer | Open-market sale | Class A Common Stock | 330 | $9.64 | $3K | |
| Steven P. Coen - Officer | Option exercise | Restricted Stock Units | 587 | - | - | |
| Steven P. Coen - Officer | Option exercise | Restricted Stock Units | 156 | - | - | |
| Harry Sloan | Other | Class A Common Stock | 4,222 | - | - | |
| Sri Kosuri - Director | Grant or award | Stock Option | 60,240 | $0.00 | - | |
| Sri Kosuri - Director | Grant or award | Stock Option | 30,911 | $0.00 | - | |
| Sri Kosuri - Director | Grant or award | Restricted Stock Units | 24,067 | $0.00 | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 1,634 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 453 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 572 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 36 | - | - | |
| Mark E. Dmytruk - Officer | Open-market sale | Class A Common Stock | 1,322 | $7.58 | $10K | |
| Mark E. Dmytruk - Officer | Option exercise | Restricted Stock Units | 1,634 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Restricted Stock Units | 453 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Restricted Stock Units | 572 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class B Common Stock | 36 | - | - | |
| Steven P. Coen - Officer | Option exercise | Class A Common Stock | 587 | - | - | |
| Steven P. Coen - Officer | Option exercise | Class A Common Stock | 156 | - | - | |
| Steven P. Coen - Officer | Open-market sale | Class A Common Stock | 333 | $7.58 | $3K | |
| Steven P. Coen - Officer | Option exercise | Restricted Stock Units | 587 | - | - | |
| Steven P. Coen - Officer | Option exercise | Restricted Stock Units | 156 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 1,634 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 453 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 572 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class A Common Stock | 46 | - | - | |
| Mark E. Dmytruk - Officer | Open-market sale | Class A Common Stock | 1,217 | $8.35 | $10K | |
| Mark E. Dmytruk - Officer | Option exercise | Restricted Stock Units | 1,634 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Restricted Stock Units | 453 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Restricted Stock Units | 572 | - | - | |
| Mark E. Dmytruk - Officer | Option exercise | Class B Common Stock | 46 | - | - | |
| Steven P. Coen - Officer | Option exercise | Class A Common Stock | 587 | - | - | |
| Steven P. Coen - Officer | Option exercise | Class A Common Stock | 156 | - | - | |
| Steven P. Coen - Officer | Open-market sale | Class A Common Stock | 306 | $8.35 | $3K | |
| Steven P. Coen - Officer | Option exercise | Restricted Stock Units | 587 | - | - | |
| Steven P. Coen - Officer | Option exercise | Restricted Stock Units | 156 | - | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Coen Steven P. | Officer | 330 | $2K | View on EDGAR | |
| Che Austin | Officer | 2,200 | $15K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Ginkgo Bioworks Holdings, Inc. (DNA) had 9 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for DNA runs to 37 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of DNA were filed in the last 90 days.
2 insider sales of DNA were filed in the last 90 days, totaling $8K.
This page tracks DNA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add DNA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
